Analyst Price Target is $10.33
▲ +58.49% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for scPharmaceuticals in the last 3 months. The average price target is $10.33, with a high forecast of $15.00 and a low forecast of $6.00. The average price target represents a 58.49% upside from the last price of $6.52.
Current Consensus is
The current consensus among 3 polled investment analysts is to buy stock in scPharmaceuticals. This Buy consensus rating has held steady for over two years.